Psychosomatic Disorders: Clinical Trials

1 trial for Psychosomatic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Psychosomatic Disorders: new trials by email Literature Review of Psychosomatic Disorders trials Research Report on Psychosomatic Disorders

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28

Narrower conditions

Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Acamprosate (1)  ·  Alprazolam (1)  ·  Amisulpride (1)  ·  Amitriptyline (1)  ·  Aripiprazole (1)  ·  Benperidol (1)  ·  Biperiden (1)  ·  Bromazepam (1)  ·  Bupropion (1)  ·  Buspirone (1)  ·  Carbamazepine (1)  ·  Chloral Hydrate (1)  ·  Chlormethiazole (1)  ·  Chlorprothixene (1)  ·  Citalopram (1)

Sponsors

Hannover Medical School (1)

Countries

Germany (1)

Top investigators

Helge Frieling, Prof., MD (1)